Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.

Young Bin JooYoung Mo KangHyoun-Ah KimChang-Hee SuhTae-Jong KimYong-Wook ParkJisoo LeeJoo-Hyun LeeDae Hyun YooSang-Cheol BaeHye-Soon LeeSo-Young Bang

Published in: International journal of rheumatic diseases (2018)

Response to current induction therapy for LN was favorable, and 6 months response following induction therapy was the most important predictor for renal survival.

Keyphrases

free survival
low dose
high dose
mesenchymal stem cells
bone marrow
replacement therapy